Circulating Methylated DNA: A New Generation of Tumor Markers

Clinical Cancer Research- United States

doi 10.1158/1078-0432.ccr-06-2531

Full Text

Abstract

Available in

Date

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

Concordance of Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Breast Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

MA15.06 Circulating Tumor DNA Portrays the Resistance Landscape to a Novel Third Generation EGFR Inhibitor, AC0010

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Circulating Cell-Free Methylated DNA and Lactate Dehydrogenase Release in Colorectal Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2014English

Detection of Circulating Tumor DNA From Pancreatic Cancer Using Next-Generation Sequencing and Possible Clinical Applications

Suizo
2018English

Correlation Between Tumor-Specific Mutated and Methylated DNA in Colorectal Cancer

JCO Precision Oncology
Cancer ResearchOncology
2019English

New Screening Test Improves Detection of Prostate Cancer Using Circulating Tumor Cells and Prostate-Specific Markers

Frontiers in Oncology
Cancer ResearchOncology
2020English

Biological Rationale for Radiation-Induced Release of Circulating Tumor DNA

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

Patient Monitoring Through Liquid Biopsies Using Circulating Tumor DNA

International Journal of Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy